🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or prison.

Service Reaction and Content Removal

Based on the social media company, the platform has removed problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Trading Activities

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

Within moments of entering one group, a vendor shared WhatsApp details, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.

Product Details and Costs

Inside these groups, messages display dark colored packages with postal service labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject users to potentially serious medical dangers”.